ID

21644

Descrição

CyberKnife Radiosurgery for Localized Prostatic Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01045148

Link

https://clinicaltrials.gov/show/NCT01045148

Palavras-chave

  1. 27/04/2017 27/04/2017 -
Transferido a

27 de abril de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Prostate Cancer NCT01045148

Eligibility Prostate Cancer NCT01045148

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed adenocarcinoma of the prostate, clinical stage t1b - t2b (ajcc 6th edition, see appendix ii), nx/n0, m0.
Descrição

Adenocarcinoma of prostate and tumor stage

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0007112
UMLS CUI [2]
C1300072
karnofsky performance status > 80.
Descrição

Karnofsky Performance Status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0206065
patient must be ≥ 18 years of age.
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
gleason sum < or = 7
Descrição

Gleason Score

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0332326
prostate-specific antigen < or = 20 ng/ml
Descrição

PSA measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201544
patients must sign a study-specific informed consent form prior to study entry.
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
stage < t1b, t2c, t3 or t4 disease (ajcc 6th edition, see appendix ii).
Descrição

Tumor Stage

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1300072
gleason score > 7.
Descrição

High gleason Score

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0205250
UMLS CUI [1,2]
C0332326
psa > 20 ng/ml.
Descrição

High PSA level

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0205250
UMLS CUI [1,2]
C0201544
lymph node involvement (n1).
Descrição

Lymph node involvement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0806692
evidence of distant metastases (m1).
Descrição

Metastases

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0027627
radical surgery for carcinoma of the prostate, prior pelvic radiation, pelvic surgical clips or other metallic foreign bodies.
Descrição

Radical surgery, prior pelvic radiation, pelvic surgical clips or metallic foreign bodies

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0194820
UMLS CUI [2,1]
C0279134
UMLS CUI [2,2]
C0436276
UMLS CUI [3]
C0038917
UMLS CUI [4]
C1720389
history of hormonal therapy (antiandrogen or 5 alpha reductase treatment within three months prior to treatment).
Descrição

Prior hormone therapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1514460
previous or concurrent cancers other than basal, in situ, or squamous cell skin cancers unless disease-free for ≥ 5 years.
Descrição

Prior malignancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2735088
major medical or psychiatric illness, which in the investigator's opinion, would prevent completion of treatment and would interfere with follow-up.
Descrição

Mental disorder

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0004936
metallic hip prosthesis.
Descrição

Metallic hip prosthesis

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019560
history of inflammatory bowel disease
Descrição

Inflammatory bowel disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021390

Similar models

Eligibility Prostate Cancer NCT01045148

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate and tumor stage
Item
histologically confirmed adenocarcinoma of the prostate, clinical stage t1b - t2b (ajcc 6th edition, see appendix ii), nx/n0, m0.
boolean
C0007112 (UMLS CUI [1])
C1300072 (UMLS CUI [2])
Karnofsky Performance Status
Item
karnofsky performance status > 80.
boolean
C0206065 (UMLS CUI [1])
Age
Item
patient must be ≥ 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Gleason Score
Item
gleason sum < or = 7
boolean
C0332326 (UMLS CUI [1])
PSA measurement
Item
prostate-specific antigen < or = 20 ng/ml
boolean
C0201544 (UMLS CUI [1])
Informed Consent
Item
patients must sign a study-specific informed consent form prior to study entry.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Tumor Stage
Item
stage < t1b, t2c, t3 or t4 disease (ajcc 6th edition, see appendix ii).
boolean
C1300072 (UMLS CUI [1])
High gleason Score
Item
gleason score > 7.
boolean
C0205250 (UMLS CUI [1,1])
C0332326 (UMLS CUI [1,2])
High PSA level
Item
psa > 20 ng/ml.
boolean
C0205250 (UMLS CUI [1,1])
C0201544 (UMLS CUI [1,2])
Lymph node involvement
Item
lymph node involvement (n1).
boolean
C0806692 (UMLS CUI [1])
Metastases
Item
evidence of distant metastases (m1).
boolean
C0027627 (UMLS CUI [1])
Radical surgery, prior pelvic radiation, pelvic surgical clips or metallic foreign bodies
Item
radical surgery for carcinoma of the prostate, prior pelvic radiation, pelvic surgical clips or other metallic foreign bodies.
boolean
C0194820 (UMLS CUI [1])
C0279134 (UMLS CUI [2,1])
C0436276 (UMLS CUI [2,2])
C0038917 (UMLS CUI [3])
C1720389 (UMLS CUI [4])
Prior hormone therapy
Item
history of hormonal therapy (antiandrogen or 5 alpha reductase treatment within three months prior to treatment).
boolean
C1514460 (UMLS CUI [1])
Prior malignancy
Item
previous or concurrent cancers other than basal, in situ, or squamous cell skin cancers unless disease-free for ≥ 5 years.
boolean
C2735088 (UMLS CUI [1])
Mental disorder
Item
major medical or psychiatric illness, which in the investigator's opinion, would prevent completion of treatment and would interfere with follow-up.
boolean
C0004936 (UMLS CUI [1])
Metallic hip prosthesis
Item
metallic hip prosthesis.
boolean
C0019560 (UMLS CUI [1])
Inflammatory bowel disease
Item
history of inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial